Form 8-K - Current report:
SEC Accession No. 0001741830-24-000070
Filing Date
2024-11-27
Accepted
2024-11-26 19:23:35
Documents
13
Period of Report
2024-11-22
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K kron-20241122.htm   iXBRL 8-K 31854
  Complete submission text file 0001741830-24-000070.txt   160141

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kron-20241122.xsd EX-101.SCH 1801
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kron-20241122_lab.xml EX-101.LAB 22548
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kron-20241122_pre.xml EX-101.PRE 13062
15 EXTRACTED XBRL INSTANCE DOCUMENT kron-20241122_htm.xml XML 2818
Mailing Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402
Business Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402 (650) 781-5200
Kronos Bio, Inc. (Filer) CIK: 0001741830 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39592 | Film No.: 241505913
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)